![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Cordis’ Vascular Closure Device Receives CE Mark
Cordis’ Vascular Closure Device Receives CE Mark
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Cordis_Logo.png?t=1567118958&width=430)
August 29, 2019
Cordis has obtained the CE Mark for its Mynx Control vascular closure device (VCD), a product used in patients who have undergone diagnostic or interventional vascular procedures.
The device is designed to achieve hemostasis and ambulation in patients at a faster rate, using active extravascular sealing and full resorbability into a new delivery system to close femoral arterial access sites.
The system automates multiple procedure steps and provides visual confirmation of the device’s positioning for proper sealant deployment.
Upcoming Events
-
21Oct